UK health advisors have recommended that prostate cancer screening be offered only to men at highest risk for the disease, rather than to the broader male population.

According to the guidance, screening should be limited to men who have both a dangerous genetic variant and a family history of cancer. This represents a targeted approach that focuses resources on those most likely to benefit from early detection.

The recommendation affects what advisors describe as "a few thousand" high-risk men across the UK. This selective screening approach contrasts with broader population-wide screening programs for other cancers.

Prostate cancer remains one of the most common cancers affecting men, but screening the general population has raised concerns about overdiagnosis and unnecessary treatment of slow-growing tumors that may never cause harm.

The new guidelines reflect ongoing debates in medical communities about balancing the benefits of early cancer detection against the risks of overtreatment and patient anxiety from screening programs.